Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIX4414 oral rotavirus vaccine in HIV-infected infants
ISRCTN11877362Phase 2Completed
- Sponsor
- World Health Organization
- Start
- Jan 2004
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 2, randomised, double-blind trial in rotaviral diarrhea comparing RIX4414 vaccine with Placebo (2 arms). Primary endpoint: Grade 2 or 3 fever, vomiting, or diarrhea after each dose. Started Jan 2004; status: completed.
02
Drugs
human rotavirus RIX4414 strain vaccine
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on ISRCTN11877362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11877362.